Financial reports
ARS
2023 FY
Annual report to shareholders
26 Apr 24
10-K
2023 FY
Annual report
26 Feb 24
10-Q
2023 Q3
Quarterly report
6 Nov 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
10-Q
2023 Q1
Quarterly report
8 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
27 Feb 23
10-Q
2022 Q3
Quarterly report
7 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
9 May 22
Current reports
8-K
Departure of Directors or Certain Officers
26 Apr 24
8-K/A
Departure of Directors or Certain Officers
26 Apr 24
8-K
Departure of Directors or Certain Officers
3 Apr 24
8-K
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
26 Feb 24
8-K
Hims & Hers Health, Inc. Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Outlook
6 Nov 23
8-K
Hims & Hers Health, Inc. Reports Second Quarter 2023 Financial Results and Raises Full Year 2023 Outlook
7 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
7 Jun 23
8-K
Hims & Hers Health, Inc. Reports First Quarter 2023 Financial Results and Raises Full Year 2023 Outlook
8 May 23
8-K
Hims & Hers Health, Inc. Reports Record Fourth Quarter and Full Year 2022 Financial Results
27 Feb 23
8-K
Departure of Directors or Certain Officers
23 Feb 23
Registration and prospectus
S-8
Registration of securities for employees
26 Feb 24
S-8
Registration of securities for employees
28 Feb 23
S-8
Registration of securities for employees
9 Mar 22
424B3
Prospectus supplement
10 Feb 22
POS AM
Prospectus update (post-effective amendment)
4 Feb 22
424B3
Prospectus supplement
20 Jan 22
424B3
Prospectus supplement
18 Nov 21
424B3
Prospectus supplement
10 Nov 21
424B3
Prospectus supplement
10 Nov 21
424B3
Prospectus supplement
7 Sep 21
Proxies
DEF 14A
Definitive proxy
26 Apr 24
DEF 14A
Definitive proxy
28 Apr 23
DEF 14A
Definitive proxy
29 Apr 22
DEF 14A
Definitive proxy
17 May 21
Other
UPLOAD
Letter from SEC
14 Oct 22
CORRESP
Correspondence with SEC
11 Oct 22
UPLOAD
Letter from SEC
27 Sep 22
EFFECT
Notice of effectiveness
8 Feb 22
EFFECT
Notice of effectiveness
4 Jun 21
EFFECT
Notice of effectiveness
24 Mar 21
EFFECT
Notice of effectiveness
12 Feb 21
CORRESP
Correspondence with SEC
11 Feb 21
UPLOAD
Letter from SEC
10 Feb 21
EFFECT
Notice of effectiveness
30 Dec 20
Ownership
4
Soleil Boughton
16 Apr 24
144
Notice of proposed sale of securities
15 Apr 24
4
Melissa Baird
8 Apr 24
4
Andrew Dudum
8 Apr 24
144
Notice of proposed sale of securities
8 Apr 24
144
Notice of proposed sale of securities
5 Apr 24
3
Christopher D Payne
4 Apr 24
144
Notice of proposed sale of securities
4 Apr 24
4
Soleil Boughton
2 Apr 24
144
Notice of proposed sale of securities
1 Apr 24